Core Viewpoint - Investors are increasingly seeking growth stocks that demonstrate above-average growth potential, with Frontdoor (FTDR) identified as a promising candidate due to its favorable growth metrics and strong Zacks Rank [1][2]. Group 1: Earnings Growth - Frontdoor has a historical EPS growth rate of 17.1%, with projected EPS growth of 8.8% for the current year, surpassing the industry average of 8.5% [4]. - Double-digit earnings growth is preferred by growth investors as it indicates strong future prospects and potential stock price gains [3]. Group 2: Asset Utilization - Frontdoor's asset utilization ratio (sales-to-total-assets ratio) stands at 1.03, indicating that the company generates $1.03 in sales for every dollar in assets, which is higher than the industry average of 0.82 [5]. Group 3: Sales Growth - The company's sales are projected to grow by 11.9% this year, significantly outpacing the industry average growth of 0.3% [6]. Group 4: Earnings Estimate Revisions - There has been a positive trend in earnings estimate revisions for Frontdoor, with the Zacks Consensus Estimate for the current year increasing by 5.3% over the past month [8][7]. Group 5: Overall Assessment - Frontdoor has achieved a Growth Score of A and holds a Zacks Rank 1, indicating it is a potential outperformer and a solid choice for growth investors [10].

Core Viewpoint - Investors are increasingly seeking growth stocks that demonstrate above-average growth potential, with RBC Bearings identified as a strong candidate due to its favorable growth metrics and Zacks Rank [2][9]. Earnings Growth - RBC Bearings has a historical EPS growth rate of 25.7%, with projected EPS growth of 14.7% for the current year, significantly outperforming the industry average of 7% [5]. Cash Flow Growth - The company exhibits a year-over-year cash flow growth of 8.3%, surpassing the industry average of 2.9%. Additionally, its annualized cash flow growth rate over the past 3-5 years stands at 21.3%, compared to the industry average of 9% [6][7]. Earnings Estimate Revisions - There has been a positive trend in earnings estimate revisions for RBC Bearings, with the Zacks Consensus Estimate for the current year increasing by 0.9% over the past month, indicating strong near-term stock price potential [8]. Overall Assessment - RBC Bearings has achieved a Growth Score of B and holds a Zacks Rank of 2, suggesting it is a solid choice for growth investors and a potential outperformer in the market [9][10].

Core Viewpoint - Investors are seeking growth stocks that can deliver above-average growth and exceptional returns, but identifying such stocks can be challenging due to their inherent risks and volatility [1] Group 1: Growth Stock Identification - The Zacks Growth Style Score system simplifies the identification of growth stocks by analyzing a company's real growth prospects beyond traditional metrics [2] - Aecom Technology (ACM) is highlighted as a recommended growth stock, possessing a favorable Growth Score and a top Zacks Rank [2] Group 2: Earnings Growth - Earnings growth is a critical factor for growth investors, with double-digit growth being particularly attractive as it indicates strong future prospects [3] - Aecom's historical EPS growth rate is 17.9%, with projected EPS growth of 15.9% this year, significantly outperforming the industry average of 10.7% [4] Group 3: Asset Utilization - The asset utilization ratio, or sales-to-total-assets (S/TA) ratio, is an important metric for assessing a growth stock's efficiency in generating sales [5] - Aecom's S/TA ratio is 1.34, indicating that the company generates $1.34 in sales for every dollar in assets, compared to the industry average of 1.18 [5] Group 4: Sales Growth - Sales growth is another key indicator of a company's attractiveness, with Aecom expected to achieve a sales growth of 5.6% this year, far exceeding the industry average of 0.2% [6] Group 5: Earnings Estimate Revisions - Trends in earnings estimate revisions are crucial, as positive revisions correlate strongly with stock price movements [7] - Aecom's current-year earnings estimates have been revised upward, with the Zacks Consensus Estimate increasing by 1.7% over the past month [7] Group 6: Overall Assessment - Aecom has earned a Growth Score of B and a Zacks Rank of 2 due to positive earnings estimate revisions, indicating it is a potential outperformer and a solid choice for growth investors [9]

Core Viewpoint - The article highlights BJ's Restaurants (BJRI) as a strong growth stock, supported by its favorable Growth Score and Zacks Rank, indicating potential for solid returns for growth investors [2][10]. Group 1: Earnings Growth - BJ's Restaurants has a historical EPS growth rate of 189.6%, with projected EPS growth of 38.5% this year, significantly outperforming the industry average of 7.9% [4]. - Earnings growth is emphasized as a critical factor for attracting investor attention, particularly double-digit growth which signals strong prospects [3]. Group 2: Asset Utilization - The company has an asset utilization ratio (sales-to-total-assets ratio) of 1.34, indicating it generates $1.34 in sales for every dollar in assets, compared to the industry average of 0.97, showcasing superior efficiency [5]. Group 3: Sales Growth - BJ's Restaurants is expected to achieve a sales growth of 3.2% this year, exceeding the industry average of 2.5%, indicating a strong position in terms of sales performance [6]. Group 4: Earnings Estimate Revisions - The current-year earnings estimates for BJ's Restaurants have been revised upward, with the Zacks Consensus Estimate increasing by 6.9% over the past month, suggesting positive momentum [8][7]. Group 5: Overall Assessment - BJ's Restaurants has earned a Growth Score of A and a Zacks Rank 1, indicating it is a potential outperformer and a solid choice for growth investors [10].

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying strong growth stocks can be challenging due to associated risks and volatility [1] Group 1: Growth Stock Identification - The Zacks Growth Style Score system aids in identifying promising growth stocks by analyzing real growth prospects beyond traditional metrics [2] - Microsoft (MSFT) is currently recommended as a strong growth stock, supported by a favorable Growth Score and a top Zacks Rank [2] Group 2: Earnings Growth - Earnings growth is a critical factor for growth investors, with double-digit growth being particularly attractive as it signals strong future prospects [3] - Microsoft's historical EPS growth rate stands at 15.5%, with projected EPS growth of 12.2% this year, surpassing the industry average of 12.1% [4] Group 3: Cash Flow Growth - High cash flow growth is essential for growth-oriented companies, enabling them to fund new projects without relying on external financing [5] - Microsoft exhibits a year-over-year cash flow growth of 23.1%, significantly higher than the industry average of 9.4% [5] - The company's annualized cash flow growth rate over the past 3-5 years is 17.9%, compared to the industry average of 10.8% [6] Group 4: Earnings Estimate Revisions - Positive trends in earnings estimate revisions are correlated with stock price movements, making them an important consideration for investors [7] - Microsoft's current-year earnings estimates have been revised upward, with a 1.5% increase in the Zacks Consensus Estimate over the past month [7] Group 5: Overall Assessment - Microsoft holds a Zacks Rank of 2 and a Growth Score of B, indicating its potential as an outperformer and a solid choice for growth investors [9]

Core Insights - Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported strong second quarter results, surpassing both EPS and revenue expectations [2] - The Eylea franchise continues to show weakness, which is expected to persist in the future [2] Financial Performance - The company achieved better-than-expected earnings per share (EPS) and revenue for the second quarter [2] - Specific financial figures were not disclosed in the provided content, but the performance indicates a positive trend in overall financial health [2] Product Analysis - The Eylea franchise is facing ongoing challenges, which may impact future revenue [2] - Dupixent remains a key product for the company, although specific performance metrics were not detailed in the content [2]

Core Viewpoint - Investors are increasingly seeking growth stocks that demonstrate above-average growth potential, with Yum Brands identified as a strong candidate due to its favorable growth metrics and Zacks Rank [1][2]. Earnings Growth - Yum Brands has a historical EPS growth rate of 9.9%, but projected EPS growth for the current year is expected to be 10%, significantly outperforming the industry average of 6.7% [4]. Asset Utilization Ratio - The company's asset utilization ratio stands at 1.18, indicating that Yum generates $1.18 in sales for every dollar in assets, compared to the industry average of 0.97, showcasing superior efficiency [5]. Sales Growth - Yum's sales are projected to grow by 6.9% this year, which is notably higher than the industry average growth rate of 2.4% [6]. Earnings Estimate Revisions - There has been a positive trend in earnings estimate revisions for Yum, with the Zacks Consensus Estimate for the current year increasing by 0.3% over the past month, indicating favorable market sentiment [8]. Overall Assessment - Yum Brands has achieved a Growth Score of A and holds a Zacks Rank of 2, reflecting its strong growth potential and positive earnings revisions, making it a solid choice for growth investors [9][10].

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying those with true potential can be challenging due to associated risks and volatility [1] Group 1: Company Overview - Bath & Body Works (BBWI) is currently recommended as a growth stock by the Zacks Growth Style Score system, which evaluates a company's real growth prospects beyond traditional metrics [2] - The company has a favorable Growth Score and a top Zacks Rank, indicating strong investment potential [2][10] Group 2: Earnings Growth - Earnings growth is a critical factor for growth investors, with double-digit growth being particularly desirable [4] - Bath & Body Works has a projected EPS growth of 5.7% this year, significantly higher than the industry average of 2.9% [5] Group 3: Asset Utilization - The asset utilization ratio, or sales-to-total-assets (S/TA) ratio, is an important metric for assessing efficiency in generating sales [6] - Bath & Body Works has an S/TA ratio of 1.49, outperforming the industry average of 1.28, indicating better efficiency [7] Group 4: Sales Growth - The company is also well-positioned for sales growth, with an expected increase of 2.4% this year compared to the industry average of 1.2% [7] Group 5: Earnings Estimate Revisions - Positive trends in earnings estimate revisions are correlated with stock price movements [8] - Bath & Body Works has seen upward revisions in current-year earnings estimates, with a 0.7% increase in the Zacks Consensus Estimate over the past month [8] Group 6: Investment Positioning - Bath & Body Works has achieved a Growth Score of A and a Zacks Rank of 2 due to positive earnings estimate revisions, positioning it well for potential outperformance [10]

Core Viewpoint - Growth investors are focused on stocks with above-average financial growth, but identifying such stocks can be challenging due to associated risks and volatility [1] Group 1: Growth Stock Identification - The Zacks Growth Style Score system aids in identifying growth stocks by analyzing a company's real growth prospects beyond traditional metrics [2] - Nasdaq (NDAQ) is currently recommended as a strong growth stock, possessing a favorable Growth Score and a top Zacks Rank [2] Group 2: Earnings Growth - Earnings growth is crucial for investors, with double-digit growth being a strong indicator of future stock price gains [4] - Nasdaq's projected EPS growth for this year is 16.4%, significantly higher than the industry average of 8.6% [5] Group 3: Cash Flow Growth - Higher-than-average cash flow growth is essential for growth-oriented companies, allowing them to expand without relying on external funding [6] - Nasdaq's year-over-year cash flow growth stands at 27.8%, surpassing the industry average of 14.1% [6] - The company's annualized cash flow growth rate over the past 3-5 years is 17%, compared to the industry average of 12.8% [7] Group 4: Earnings Estimate Revisions - Positive trends in earnings estimate revisions correlate strongly with near-term stock price movements [8] - Nasdaq's current-year earnings estimates have increased by 2.7% over the past month [8] Group 5: Overall Assessment - Nasdaq has achieved a Zacks Rank of 2 and a Growth Score of B, indicating its potential as an outperformer and a solid choice for growth investors [10]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying strong candidates can be challenging due to inherent risks and volatility [1] Group 1: Company Overview - Amneal Pharmaceuticals (AMRX) is highlighted as a promising growth stock with a favorable Growth Score and a top Zacks Rank [2] - The company has a historical EPS growth rate of 2%, but projected EPS growth for this year is expected to be 23%, significantly higher than the industry average of 14.9% [5] Group 2: Financial Metrics - Amneal's asset utilization ratio (sales-to-total-assets ratio) stands at 0.82, indicating that the company generates $0.82 in sales for every dollar in assets, compared to the industry average of 0.45, showcasing superior efficiency [6] - The company's sales are projected to grow by 7.8% this year, while the industry average is stagnant at 0% [7] Group 3: Earnings Estimates - There is a positive trend in earnings estimate revisions for Amneal, with the current-year earnings estimates increasing by 1% over the past month, which correlates with potential near-term stock price movements [8] - Amneal has achieved a Zacks Rank of 2 (Buy) and a Growth Score of B based on various favorable metrics [9]